| Pharmaceutical active ingredients: |
| Dexrazoxane Hydrochloride |
| Available forms, composition and doses of Zinecard: |
| Injectable; Injection; Dexrazoxane Hydrochloride 250 mgInjectable; Injection; Dexrazoxane Hydrochloride 500 mg |
| Zinecard medical category: |
| Human:Cardioprotective agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AF02 - Dexrazoxane |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Related documents and information about Zinecard: |
| Zinecard prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Troxozone | Dexrazoxane | Unidentified Pharmaceutical Company |
| Cardioxane | Dexrazoxane Hydrochloride | Chiron; Asofarma de Mexico; Concept for Pharmacy; CSC Pharmaceuticals Handels; Medicom International; Novartis; Tecnofarma; Zodiac Produtos Farmaceuticos |
| Dexrazoxane | Dexrazoxane Hydrochloride | Bedford Laboratories |
| Eucardion | Dexrazoxane Hydrochloride | Dompe Farmaceutici |
| Totect | Dexrazoxane Hydrochloride | Topotarget; Ben Venue Laboratories; Hameln Pharmaceuticals; Integrated Commercialization Solutions |
| Plasmex | Dextran | Claris Lifesciences |
| Polyglucinum | Dextran | Unidentified Pharmaceutical Company |
| Polyglusol | Dextran | Unidentified Pharmaceutical Company |
| Rheopolyglucine | Dextran | Unidentified Pharmaceutical Company |
| Praedex | Dextran 1 | Fresenius |